HDR Interstitial Brachytherapy in Recurrent Head and Neck Cancer: An Effective Salvage Option

We present our results in patients with recurrent H&N cancers treated with interstitial HDRBT in terms of survival and toxicity outcomes and also assess the prognostic factors associated with reirradiation with HDR Brachytherapy.

Source: Brachytherapy - June 23, 2018 Category: Cancer & Oncology Authors: Vibhay Pareek, Rajendra Bhalavat, Manish Chandra, Lalitha Nellore, Rishi Pareek Source Type: research